mHEALTH APPLICATION AS A TOOL TO ASSIST FAMILY DOCTORS IN THE MANAGEMENT OF HYPERTENSION

Authors

  • Sashka Janevska PHO “Vita Katerina”, Skopje, Republic of North Macedonia
  • Atanas Gogjoski “Angor AG”, Struga, Republic of North Macedonia
  • Biljana Gerasimovska University Clinic for Nephrology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Katerina Kovachevikj PHO “Vita Katerina”, Skopje, Republic of North Macedonia
  • Katerina Ristoska Zan Mitrev Clinic, Skopje, Republic of North Macedonia

Keywords:

mHealth application, hypertension, family doctor, ,, face to face

Abstract

Аim: The aim of this study was to determine the impact of using a mHealth application in work organizing of primary care clinics in managing patients with newly diagnosed hypertension in RN Macedonia.

Material and methods: A prospective randomized controlled multicenter study with 12-month follow-up of newly diagnosed patients with hypertension was performed. The intervention group received standard care + mHealth application, while the control group received only standard care. The mHealth application enabled transmission of measured blood pressure values in real time and two-way doctor-patient communication via SMS messages. The study monitored the number, reasons and justification of additional visits in the primary care clinic.

Results: From 192 participants included, 75(39.06%) had an additional visit - 23(24.21%) in the intervention and 52(53.61%) in the control group (p=0.0001). In terms of the number of additional visits per patient, only 1 in the intervention versus 17 in the control group had 3 emergency examinations (p=0.004). The most common reason for examination was blood pressure measurement in 15(7.81%) patients. No adverse events were recorded in either group.

Conclusion: The mHealth application with two-way patient-doctor communication represents an additional intervention to standard care that can reduce the need for “face-to-face"visits with a family doctor and provides an opportunity for better organization of work in family doctor outpatient clinics.

References

Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011; 32: 2143-2152. doi: 10.1093/eurheartj/ehr080.

Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high, middle-, and low-income countries. JAMA 2013; 310(9): 959-968. doi: 10.1001/jama.2013.184182.

World Health Organisation. North Macedonia. Hypertension profiles, 2023 [document on the internet]. Available from: https://cdn.who.int/media/docs/default-source/country-profiles/hypertension/hypertension-2023/hypertension_mkd_2023.pdf?sfvrsn=20762a16_ 4&download=true.

Bojovski I, Stankovic S, Georgiev A, Petlichkovski A, Boshevski M. Frequency of genetic variants associated with coronary artery disease and venous thromboembolism in young patients in Republic of N. Macedonia. Acad Med J 2022; 2(1): 109-118. doi: 10.53582/AMJ2221109b.

Brunström M, Carlberg B. Association of Blood Pressure Lowering with Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis. JAMA Intern Med 2018; 178(1): 28-36. doi: 10.1001/jamainternmed.2017.6015.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913. doi: 10.1016/s0140-6736(02)11911-8.

"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021). Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2024. Available from https://vizhub.healthdata.org/gbd-results/." attribution_short: "IHME-GBD".

GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1223-1249. doi: 10.1016/S0140-6736(20)30752-2.

World Health Organization, World Health Organization, Health Topics: Hypertension. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/hypertensionLast assessed 16.03.2023.

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41(12): 1874-2071. doi: 10.1097/HJH.0000000000003480. Erratum in: J Hypertens 2024; 42(1): 194. doi: 10.1097/HJH.0000000000003621.

Milman T, Joundi RA, Alotaibi NM, Saposnik G. Clinical inertia in the pharmacological management of hypertension: A systematic review and meta-analysis. Medicine (Baltimore) 2018; 97(25): e11121. doi: 10.1097/MD.0000000000011121.

Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med 2001; 135(9): 825-834. doi: 10.7326/0003-4819-135-9-200111060-00012.

Redón J, Coca A, Lázaro P, Aguilar MD, Cabañas M, Gil N, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 2010; 28(8): 1770-1777. doi: 10.1097/HJH.0b013e32833b4953.

Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282(15): 1458-1465. doi: 10.1001/jama.282.15.1458.

Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007; 167(2): 141-147. doi: 10.1001/archinte.167.2.141. Erratum in: Arch Intern Med. 2007; 167(7): 648.

Mileski M, Kruse CS, Catalani J, Haderer T. Adopting telemedicine for the self-management of hypertension: systematic review. JMIR Med Inform 2017; 5(4): e41. doi: 10.2196/medinform.6603.

Wang S, Leung M, Leung SY, Han J, Leung W, Hui E, et al. Safety, Feasibility, and Acceptability of Telemedicine for Hypertension in Primary Care: A Proof-of-concept and Pilot Randomized Controlled Trial (SATE-HT). J Med Syst 2023; 47(1): 34. doi: 10.1007/s10916-023-01933-4. Erratum in: J Med Syst 2023 Jul 5; 47(1): 68. doi: 10.1007/s10916-023-01965-w.

Hammersley V, Parker R, Paterson M, Hanley J, Pinnock H, Padfield P, et al. Telemonitoring at scale for hypertension in primary care: An implementation study. PLoS Med 2020; 17(6): e1003124. doi: 10.1371/journal.pmed.1003124.

Downloads

Published

2025-12-16

Issue

Section

Original Articles